0000899243-19-019500.txt : 20190711 0000899243-19-019500.hdr.sgml : 20190711 20190711210024 ACCESSION NUMBER: 0000899243-19-019500 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190709 FILED AS OF DATE: 20190711 DATE AS OF CHANGE: 20190711 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Snyder Douglas B. CENTRAL INDEX KEY: 0001754125 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35892 FILM NUMBER: 19951897 MAIL ADDRESS: STREET 1: SOVEREIGN HOUSE, VISION PARK, HISTON CITY: CAMBRIDGE STATE: X0 ZIP: CB249BZ ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: GW PHARMACEUTICALS PLC CENTRAL INDEX KEY: 0001351288 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 BUSINESS ADDRESS: STREET 1: SOVEREIGN HOUSE STREET 2: VISION PARK CITY: HISTON, CAMBRIDGE CB24 9BZ STATE: X0 ZIP: 00000 BUSINESS PHONE: 44 1223 266800 MAIL ADDRESS: STREET 1: SOVEREIGN HOUSE STREET 2: VISION PARK CITY: HISTON, CAMBRIDGE CB24 9BZ STATE: X0 ZIP: 00000 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2019-07-09 0 0001351288 GW PHARMACEUTICALS PLC GWPH 0001754125 Snyder Douglas B. SOVEREIGN HOUSE, VISION PARK, HISTON CAMBRIDGE X0 CB24 9BZ UNITED KINGDOM 0 1 0 0 Chief Legal Officer Ordinary Shares 2019-07-09 4 S 0 4968 14.42 D 82920 D The sales reported were effected pursuant to a Rule 10b-5 trading plan adopted by the Reporting Person on May 14, 2019. Represented by American Depositary Shares of the Issuer ("ADSs"). Each ADS represents twelve ordinary shares of the Issuer. The price reported in Column 4 is a price per ordinary share converted from price per ADS. Includes 56,376 and 26,544 ordinary shares underlying restricted stock units previously reported as stock options on the reporting person's Form 3 filed on October 1, 2018 and Form 4 filed on March 5, 2019, respectively. /s/ Douglas B. Snyder 2019-07-11